Popular terms

[SEARCH]

Sclera topics
Anterior Chamber
Conjunctiva
Aqueous Humor
Epithelium
Accommodation
Ocular Hypertension
Brachytherapy
Radionuclide
Hypertension
Laser Treatment
Retraction
Vision Loss
Presbyopia
Treatments
Cataract Surgery

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Sclera patents



      
           
This page is updated frequently with new Sclera-related patent applications. Subscribe to the Sclera RSS feed to automatically get the update: related Sclera RSS feeds. RSS updates for this page: Sclera RSS RSS


Method and apparatus for suprachoroidal administration of therapeutic agent

Janssen Research & Development

Method and apparatus for suprachoroidal administration of therapeutic agent

Fasteners, deployment systems, and methods for ophthalmic tissue closure and fixation of ophthalmic prostheses and other…

Ocunetics

Fasteners, deployment systems, and methods for ophthalmic tissue closure and fixation of ophthalmic prostheses and other…

Fasteners, deployment systems, and methods for ophthalmic tissue closure and fixation of ophthalmic prostheses and other…

Dry Eye Kt

Apparatus and method for measuring eye's moisture


Date/App# patent app List of recent Sclera-related patents
08/13/15
20150223978 
 Intraocular injection device patent thumbnailIntraocular injection device
Described is a displacement device for displacing a conjunctiva of an eye relative to a sclera. The displacement device comprises a first leg, a second leg, a bar hingedly coupled to the first leg and the second leg such that the bar can move between a refracted position and an extended position, and a finger coupled to the bar.
Sanofi-aventis Deutschland Gmbh


08/13/15
20150223977 
 Method and  suprachoroidal administration of therapeutic agent patent thumbnailMethod and suprachoroidal administration of therapeutic agent
An apparatus for delivering therapeutic agent to an eye comprises a body, a cannula, a hollow needle, and an actuation assembly. The cannula extends distally from the body and is sized and configured to be insertable between a choroid and a sclera of a patient's eye.
Janssen Research & Development, Llc


08/13/15
20150223806 
 Fasteners, deployment systems, and methods for ophthalmic tissue closure and fixation of ophthalmic prostheses and other uses patent thumbnailFasteners, deployment systems, and methods for ophthalmic tissue closure and fixation of ophthalmic prostheses and other uses
Methods and devices for ophthalmic tissue closure and fixation of ophthalmic prostheses are provided. In accordance with some embodiments, devices for both grasping and clipping a plurality of ocular tissue and ocular prostheses are provided.
Ocunetics, Inc.


08/06/15
20150216406 
 Apparatus and  measuring eye's moisture patent thumbnailApparatus and measuring eye's moisture
An apparatus for measuring eye's moisture 1 includes: a detection surface 30 placed on a position in contact with a conjunctiva, a sclera, or a cornea or a position opposed to a conjunctiva, a sclera, or a cornea; and a capacitance sensor 40 provided on the detection surface 30. As a result, an apparatus and a method for measuring eye's moisture that are capable of simply and objectively measuring the state of tear fluid are provided..
Dry Eye Kt Co., Ltd.


07/30/15
20150209179 
 Contact probe for the delivery of laser energy patent thumbnailContact probe for the delivery of laser energy
Systems, devices, and methods for treating a glaucomatous eye are provided. An amount of pulsed laser energy is delivered to the pars plana of the eye by a hand-holdable device which comprises a hand-holdable elongate member and a contact member disposed on an end of the elongate member.
Iridex Corporation


07/23/15
20150202040 
 Buttressed haptic patent thumbnailButtressed haptic
A haptic supporting an intraocular lens (iol) in the eye permits radial tension from ciliary muscle relaxation rather than contraction to alter the lens power. The iol is supported by the overlying tissue in the eye such as iris root, sclera and ciliary process, so that anterior and posterior forces on iol are balanced, and buckling or displacement of lens in the eye or haptic is reduced or prevented.
The Arizona Board Of Regents On Behalf Of The University Of Arizona


07/02/15
20150182725 
 Versatile light-guided ophthalmic treatment system patent thumbnailVersatile light-guided ophthalmic treatment system
A light-guided, ophthalmic-treatment-system for administering therapeutic agents to, into or through the scleral wall of the eye globe using any one of a variety of therapeutic applicators in conjunction with either transcorneal or transpupillary viewing methods or both.. .
Ip Liberty Vision Corporation


07/02/15
20150182659 
 Methods and kits for reversible adhesion of implants to an eye sclera patent thumbnailMethods and kits for reversible adhesion of implants to an eye sclera
Methods and kits are provided for reversibly affixing an implant to a sclera of an eye of a subject. The methods and kits are based on applying a composition comprising at least one fibrin-based tissue adhesive to at least one of said implant and said sclera, thereby affixing said implant to the sclera, and applying a composition comprising at least one plasminogen activator to at least one of said implant and said sclera following a desired time-period, thereby detaching said implant from said sclera, and removing said implant from said eye..
Tel Hashomer Medical Research Infrastructure And Services Ltd.


06/11/15
20150157715 
 Photokinetic ocular drug delivery methods and apparatus patent thumbnailPhotokinetic ocular drug delivery methods and apparatus
The present invention relates generally to transscleral, transcorneal, and transocular delivery of biologically active substances through the tissues, blood vessels and cellular membranes of the eyes of patients without causing damage to the cellular surface, tissue or membrane. The invention provides compositions and methods for enhanced transscleral, transcorneal and transocular delivery of biologically active substances using pulsed incoherent light, and particularly the transcleral, transcorneal or transocular delivery of high molecular weight biologically active substances to a patient using pulsed incoherent light.
Board Of Regents, The University Of Texas System


06/11/15
20150157504 
 Drainage device and  producing same patent thumbnailDrainage device and producing same
The invention relates to medical technology and is intended for use in ophthalmology in the surgical treatment of various types of glaucoma. According to a first aspect of the invention, the drainage device for use in the surgical treatment of glaucoma is formed from a bioresorbable material in the form of a hollow profile with a closed contour in cross section, ensuring the possibility of the scleral flap passing through the cavity of the device during the surgical treatment.

05/28/15
20150148899 

Sodium channel blocker delivery system with scleral lens


A scleral lens is provided with a sodium channel blocker or a sodium channel modulator disposed in the pre-corneal tear film between the scleral lens and the cornea. This system can be used to deliver sodium channel blockers or a sodium channel modulators not currently used because of poor bioavailability.
Boston Foundation For Sight


05/21/15
20150139973 

Ophthalmological vehicle system for drugs, ophthalmological kit and also use of an ophthalmological composition


The present invention relates to an ophthalmological vehicle system for the permeation and/or for the active substance transport of ophthalmological active substances through the cornea and/or the sclera of the eye of mammals. This vehicle system assists the transport of the active substances through the cornea and/or the sclerotic tissue of the eye.
F. Holzer Gmbh


05/21/15
20150136990 

Visual display with illuminators for gaze tracking


A visual display includes hidden reference illuminators adapted to emit invisible light for generating corneo-scleral reflections on an eye watching a screen surface of the display. The tracking of such reflections and the pupil center provides input to gaze tracking.
Tobii Technology Ab


05/14/15
20150133896 

Bioresorbable drug eluting intravitreal implant system and method


A bioresorbable drug eluting intravitreal implant system includes a syringe with a chamber containing a medicinal drug. A balloon is releasably secured to a needle where the needle has a central section chamber in fluid communication with a chamber in the syringe.

05/14/15
20150131055 

Systems and methods for mapping the ocular surface


Examples of methods and apparatus for an accurate measurement of the anterior surface of the eye including the corneal and scleral regions are disclosed. The measurements provide a three-dimensional map of the surface which can be used for a variety of ophthalmic and optometric applications from astigmatism and keratoconus diagnostics to scleral lens fitting..

05/07/15
20150127014 

Method and preparation and insertion of an intraocular lens into the eye of a patient


A method for insertion of an intraocular lens into the eye of a patient, the method including removably attaching loop extensions to loops of an intraocular lens prior to insertion of the intraocular lens into the eye of a patient, initially inserting into the eye of the patient the loop extensions, pulling on the loop extensions through sclerectomies formed in the sclera of the eye of the patient, inserting the intraocular lens into the eye of the patient, positioning the intraocular lens in a desired position in the eye of the patient by pulling on the loop extensions through the sclerectomies, and fixing the loops to the sclera of the eye of the patient at the sclerectomies and detaching the loop extensions from the loops.. .
Visioncare Ophthalmic Technologies Inc.


04/23/15
20150112372 

Method and trabeculectomy and suprachoroidal shunt surgery


A medical device and surgical procedure for the treatment of glaucoma in patients with primary open angle glaucoma, secondary open angle glaucoma, closed angle glaucoma, and refractory glaucoma. The device is inserted between two scleral flaps, cutting the trabecular meshwork and the sclera.

04/23/15
20150112282 

Hollow microneedle and subretinal syringe for subretinal injection or extraction


The present invention relates to a method for manufacturing a hollow microneedle for subretinal injection or extraction. The microneedle for subretinal injection or extraction is made of metal, thereby providing the strength and force for penetrating the sclera and retina.
Industry-academic Cooperation Foundation, Yonsei University


04/09/15
20150100010 

Glaucoma drainage shunts and methods use


A method of treating glaucoma in an eye utilizing an implanted shunt having an elastomeric plate and a non-valved elastomeric drainage tube. The plate is positioned over a sclera of the eye with an outflow end of the elastomeric drainage tube open to an outer surface of the plate.
Abbott Medical Optics Inc.


04/02/15
20150094805 

Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods


A system includes a scleral prosthesis and an insert. The scleral prosthesis includes an elongated body having a first free end and a second free end opposite the first end.
Refocus Group, Inc.


03/26/15
20150088297 

System and designing scleral lenses


A system and method for designing scleral lenses includes a computer, a camera and a lathe connected by a network. The camera captures a set of sagittal images at each of a set of sagittal planes of an eye.

03/26/15
20150085246 

Progressive multifocal rigid gas permeable contact lens


A large diameter, rigid, gas permeable, corneal-scleral progressive, multifocal vision contacty lens that covers the cornea and a portion of the sclera of an eye. It is particularly beneficial for use on patients who have undergone refractive surgery and/or on patients experiencing presbyopia.
Dakota Sciences, Inc.


03/19/15
20150078629 

Template update for biometric authentication


An enrollment template can be a collection of interest points such as vascular points (vpd) and corresponding features such as enhanced multi-radii local binary patterns (emr-lbp), pattern histograms of enhanced multi-radii local binary patterns (ph-emr-lbp), pattern histograms of enhanced multi-radii center-symmetric local binary patterns (ph-emr-cs-lbp), and enhanced multi-radii center-symmetric local binary patterns (emr-cs-lbp). In some implementations, an enrollment template can be created only if the acquired image exceeds a certain threshold based on ratio of vpd points to that of size of segmented scleral region.
Eyeverify, Inc.


03/19/15
20150078626 

Animal / pet identification system and method based on biometrics


An animal identification system and method is provided. The system includes a biometric sensor configured to capture a biometric feature of an animal as a biometric representation of the animal and a biometric identification module configured to receive the biometric representation of the animal and compare said biometric representation of the animal with stored biometric data for a plurality of animals and evaluate matching characteristics between the biometric representation of the animal and stored biometric data for the plurality of animals.

03/05/15
20150065940 

Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye


Delivery devices, systems and methods are provided for inserting an implant into an eye. The delivery or inserter devices or systems can be used to dispose or implant an ocular stent or implant, such as a shunt, in communication with the suprachoroidal space, uveal scleral outflow pathway, uveoscleral outflow path or supraciliary space of the eye.
Glaukos Corporation


02/26/15
20150057701 

Systems and methods for the treatment of eye conditions


Systems, methods, and devices used to treat eyelids, meibomian glands, ducts, and surrounding tissue are described herein. In some embodiments, an eye treatment device is disclosed, which includes a scleral shield positionable proximate an inner surface of an eyelid, the scleral shield being made of, or coated with, an energy-absorbing material activated by a light energy, and an energy transducer positionable outside of the eyelid, the energy transducer configured to provide light energy at one or more wavelengths, including a first wavelength selected to heat the energy-absorbing material..

02/26/15
20150057591 

Methods for intraocular shunt placement


Intraocular pressure can be reduced by insertion of an intraocular shunt in the eye such that it forms a drainage pathway between the anterior chamber and a region of lower pressure. A hollow shaft can be advanced through the anterior chamber with the hollow shaft (a) having a beveled tip at a distal end of the hollow shaft and (b) holding an intraocular shunt with a proximal end of the shunt within the hollow shaft.
Aquesys, Inc.


02/12/15
20150045714 

Intrascleral shunt placement


Glaucoma can be treated by implanting an intraocular shunt into an eye. The eye has an anterior chamber and sclera.
Aquesys, Inc.


02/12/15
20150042477 

Eye closure detection using structured illumination


A monitoring system and method for monitoring and/or predicting drowsiness of a driver of a vehicle or a machinery operator are provided. A set of infrared, ir, or near infrared, nir, light sources, is arranged such that an amount of the light emitted from the light source incidents on an eye of the driver or operator.
Tobii Technology Ab


01/29/15
20150029461 

Cycloduction measurement device, cycloduction measurement method, and cycloduction measurement program


This cycloduction measurement device is provided with a blood vessel position recognition unit and a first angle calculation unit. The blood vessel position recognition unit recognizes the position of a blood vessel in a sclera region in an eye image, and acquires information pertaining to the position of the blood vessel.
University Of Tsukuba


01/15/15
20150018746 

Device for use in glaucoma surgery


The invention relates to a device for use in glaucoma surgery intended for implantation in the eye. The device comprises a flat head region (8), a probe (6) which adjoins the head region (8), and a relief channel (7) which extends through the head region (8) and the probe (6) and is open at both sides.
Geuder Ag


01/01/15
20150005750 

Systems and methods for the treatment of eye conditions


Systems, methods, and devices used to treat eyelids, meibomian glands, ducts, and surrounding tissue are described herein. In some embodiments, an eye treatment device is disclosed, which includes a scleral shield positionable proximate an inner surface of an eyelid, the scleral shield being made of, or coated with, an energy-absorbing material activated by a light energy, and an energy transducer positionable outside of the eyelid, the energy transducer configured to provide light energy at one or more wavelengths, including a first wavelength selected to heat the energy-absorbing material.
Tear Film Innovations Llc


01/01/15
20150005623 

Method and treating an ocular disorder


Embodiments of the claimed invention are directed to the treatment of glaucoma (or conditions of elevated intraocular pressure) using a novel ab interno trabeculotomy procedure that uses a flexible device. At least one advantage of the present method is that it does not require a conjunctival or scleral incision, which in turn improves patient recovery time and healing..
Innovative Glaucoma Solutions, Llc


12/25/14
20140378888 

(bacterio)chlorophyll photosensitizers for treatment of eye diseases and disorders


An ophthalmic composition is provided, comprising chlorophyll or bacteriochlorophyll compounds for photodynamic treatment (pdt) of diseases, disorders and conditions associated with corneal or scleral anomalies such as corneal thinning and scleral stretching.. .
Yeda Research And Development Co., Ltd.


12/25/14
20140378886 

Glaucoma treatment device


Methods and devices are adapted for implanting into the eye. An incision is formed in the cornea of the eye and a shunt is inserted through the incision into the anterior chamber of the eye.
Transcend Medical, Inc.


12/18/14
20140371852 

Scleral fixation bag


A method is described for introducing a scleral fixation bag into an eye. The scleral fixation bag includes haptics that extend therefrom.

12/18/14
20140371565 

Accommodation stimulation and recording device


Embodiments described herein generally relate to devices and methods for stimulation or recording of accommodation of an eye. Accommodation of an eye naturally occurs through contraction of the ciliary muscle.
University Of Houston System


12/11/14
20140364791 

Method and device for the treatment of glaucoma


The invention relates to a method and a device for treatment of glaucoma, wherein by means of an elongated catheter provided with a distal portion and a proximal portion, a tube-shaped implant is inserted and released in a schlemm's canal with two opposite openings exposed by an incision and a folded up scleral flap. In a first phase, the distal portion inserted into the schlemm's canal through the first opening, while a fluid or gaseous medium is injected at the same time, and exited through the second opening, which is, in circumferential direction, oppositely located.

12/11/14
20140362338 

Eye covering and refractive correction methods and apparatus having improved tear flow, comfort, and/or applicability


An eye covering such as a contact lens may comprise one or more structures to pump tear liquid under the covering such that the covering can remain in the eye and correct vision for an extended amount of time. In many embodiments, the covering comprises a material having fenestrations to draw tear liquid under the covering and an outer portion shaped to contact the conjunctiva over the sclera, such that when the eye closes pressure of one or more eyelids urges tear liquid through one or more fenestrations and under the outer portion shaped to contact the conjunctiva.

12/04/14
20140358011 

Single shot high resolution conjunctival small vessel perfusion evaluating microvasculature in systemic and ocular vascular diseases


A system and method for generating high-resolution, small vessel perfusion maps (ncpms) of the ocular conjunctival microvasculature. Unlike current systems and methods, the present invention allows for the generation of ncpms using only a single raw image obtained in a single image acquisition step.

12/04/14
20140356836 

Model newborn human eye and face manikin


A model newborn human eye which includes a hemispherical-shaped, integrally molded top assembly comprising a visually transparent cornea portion surrounding a visually opaque sclera portion in combination with a hemispherical-shaped bottom assembly comprising a bowl-shaped substrate disposed therein. The model newborn human eye further comprises a retinal layer comprising a two dimensional image of retinal vasculature disposed on said substrate, where the model newborn human eye is dimensioned for diagnosing retinopathy of prematurity (“rop”) in premature infants..

11/27/14
20140348956 

Scleral lens solution


A scleral lens solution comprising an aqueous mixture that includes sodium, potassium, calcium and magnesium cations and a ph in a range from about 6.5 to about 8.7.. .

11/13/14
20140336724 

Retinal prosthesis


The present invention relates to retinal prostheses, and in particular to the transfer of electrical power and data from outside of the human body to such a prosthesis. The retinal prosthesis comprises: a retinal electrode array implanted in the eye to stimulate the retina.

11/13/14
20140336619 

Ophthalmic shunt and method


An ophthalmic shunt includes a seal or septum through which multiple injections of the therapeutic agent can be made as needed, thereby avoiding repeated injury to the sclera. The therapeutic agent is temporarily carried in a tube connected to the septum.

10/30/14
20140323945 

Device for treatment of glaucoma and prevention of sub-scleral fibrosis and blockage


A device for treatment of glaucoma and prevention of sub-scleral fibrosis and blockage. This invention relates to a device for treatment of glaucoma comprising of a circular patch (1) with a plurality of holes wherein the patch is made of biocompatible material.

10/23/14
20140313481 

Ophthalmic apparatus


An ophthalmic apparatus for guiding positioning an intraocular lens for astigmatism correction, includes: an obtaining unit for obtaining an anterior segment image of a patient's eye and an astigmatic axis of a patient's cornea; a feature point designating unit for defining a feature point of an iris or a sclera on the anterior segment image; and a display control unit for superimposing and displaying a gauge image that models a cornea gauge and an axis that represents the astigmatic axis of the cornea on the anterior segment image.. .

10/02/14
20140296890 

Secondary pigmentary glaucoma iris scraping treatment method and iris scraping tool


An iris scraping surgical method using an iris scraping tool treats secondary pigmentary glaucoma. The iris scraping tool is inserted through an incision in the sclera made with a separate surgical instrument.

10/02/14
20140296800 

Ophthalmic implant for delivering therapeutic substances


Described are implantable therapeutic devices, systems and methods to treat a patient. The device includes a hollow refillable housing for implantation within the posterior segment of an eye through a penetration in the sclera including a proximal retention structure protruding outward from a proximal end region of the housing, an access portion opening, and a penetrable barrier positioned at least in part within the access portion opening, the penetrable barrier configured to be repeatedly penetrated.

09/25/14
20140288003 

Inhibition of collagen synthesis


Therapies and compositions for reducing collagen synthesis in mammalian cells and tissues wherein the targets are scleraxis, scleraxis-binding sites, receptor-regulated smads, and/or binding sites for receptor-regulated smads whereby synergistic interactions between scleraxis proteins and receptor-regulated smads are reduced, inhibited, interfered with, stopped, and/or prevented thereby reducing, inhibiting and/or interfering with the activation of collagen 1α2 promoter thereby inhibiting collagen production in mammalian cells and tissues. Alternatively, the therapies and compositions may reduce, inhibit, interfere with, stop, and/or prevent binding of the collagen 1α2 promoter to dna thereby inhibiting expression of the collagen 1α2 gene in mammalian cells and tissues..

09/18/14
20140277431 

Treatments of extracellular matrices of the eye


System and methods for a corrective eye procedure include at least one application device configured to be positioned at a selected area of an eye (e.g., equatorial sclera, posterior sclera, cornea, etc.). The at least one device includes at least one channel and at least one illumination guide.

09/18/14
20140277051 

Device and ciliary muscle compression for increaseing the amplitude of accommodation


The present invention relates generally to a device and method for the treatment of, ocular hypertension, glaucoma, and increasing the amplitude of accommodation. In an illustrative embodiment, the device includes a self-expanding wire.

09/18/14
20140276674 

System and ophthalmic laser surgery employing eye tracking without eye docking


A system and method for performing ophthalmic surgery using an ultra-short pulsed laser is provided. The system includes a laser engine configured to provide an ultra-short pulsed laser beam, optics configured to direct the laser beam to an undocked eye of a patient, an eye tracker configured to measure five degrees of freedom of movement of the undocked eye, an optical coherence tomography module configured to measure depth of the undocked eye, and a controller configured to control laser beam position on the undocked eye toward a desired laser pattern based on depth and the five degrees of freedom of movement of the undocked eye.

09/18/14
20140276673 

Hybrid ophthalmic interface apparatus


Apparatus and methods are provided for interfacing an ophthalmic surgical laser with an eye using a patient interface (pi). The pi may include a closed, fluid-filled bladder having fiducials that contacts and deforms to the eye.

09/18/14
20140276329 

Trans-sclera portal for delivery of therapeutic agents


A portal through the sclera for delivery of an effective amount of therapeutic agent to the back of the eye.. .

08/28/14
20140243730 

Intraocular shunt implantation methods and devices


The present invention generally relates to devices and methods of implanting an intraocular shunt into an eye. In certain aspects, methods of the invention involve creating an opening in the sclera, and positioning a shunt in the anterior chamber of the eye such that the shunt terminates via the opening in the intra-scleral space, thereby facilitating fluid flow through both the opening and the intra-scleral space..

08/28/14
20140243623 

Apparatus for monitoring one or more surgical parameters of the eye


An apparatus for monitoring one or more surgical parameters of the eye over multiple sessions which are temporally spaced apart and between which the eye of the patient can have moved, said apparatus comprising: a camera for taking one or more images of the eye; a module for determining during a first session said at least one surgical parameter of the eye and its coordinates based on the image taken by said camera in a first coordinate system; a module for determining during a second session temporally spaced apart from said first session said at least one surgical parameter of the eye and its coordinates based on the image taken by said camera in a second coordinate system; a module for determining the eye motion in six degrees of freedom between said first and said second session and for determining a coordinate transformation based thereon; a module for transforming based on said determined eye motion said at least one surgical parameter of the eye and its coordinates from said first coordinate system into said second coordinate system; a module for quantifying and/or visualizing the change of said at least one surgical parameter of the eye and its coordinates between said first and said second session based on said surgical eye parameter and its coordinates measured during said second session and said transformed surgical eye parameter and its coordinates measured during said first session, wherein said surgical eye parameters are one or more of the following: implant-related parameters of the eye which are based on an implant which has been surgically placed in the eye of a patient; or the location and/or contour of corneal or limbal or scleral incisions.. .

08/28/14
20140243583 

Method for preventing the onset and progression of myopia


The present invention relates to ophthalmology, and is designated to prevent onset and progression of myopia. The treatment course, comprising eye exposure with magnetic field, transscleral low-energy laser radiation with wavelength of 1.3 microns, and additional optical—reflectory eye trainings, is conducted.

08/21/14
20140236068 

Glaucoma shunts with flow management and improved surgical performance


A method of treating glaucoma in an eye by managing fluid flow past an implanted shunt having an elastomeric plate and a non-valved elastomeric drainage tube. The plate is positioned over a sclera of the eye with an outflow end of the elastomeric drainage tube open to an outer face of the plate.

08/21/14
20140232025 

Manufacturing shape memory polymer intraocular devices


A shape memory polymer (smp) intraocular lens may have a refractive index above 1.45, a tg between 10° c. And 60° c., inclusive, de minimis or an absence of glistening, and substantially 100% transmissivity of light in the visible spectrum.

08/07/14
20140221972 

Method for treating glaucoma


A method of treating glaucoma or other eye disease in a patient is provided. The method includes injecting an eye of the patient with a cohesive monophasic gel containing cross-linked hyaluronic acid or its salt.

08/07/14
20140219516 

System and iris detection in digital images


A system and a method for iris detection in a face region of a digital image are disclosed. In one embodiment, iris is detected in the face region of the digital image using eye features, such as a shape of the iris and/or luminance values of a sclera region..

07/31/14
20140214162 

Animatronic eye with an electromagnetic drive and fluid suspension and with video capability


An animatronic eye with fluid suspension, electromagnetic drive, and video capability. The eye assembly includes a spherical, hollow outer shell that contains a suspension liquid.

07/10/14
20140194957 

Ophthalmic treatment device, system, and use


Ophthalmic treatment systems and methods of using the systems are disclosed. The ophthalmic treatment systems include (a) a light source device; (b) at least one optical treatment head operatively coupled to the light source device, comprising a light source array, and providing at least one treatment light; and (c) a light control device, which (i) provides patterned or discontinuous treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye); or (ii) adjusts intensity of part or all of the light source array, providing adjusted intensity treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye).

06/26/14
20140180411 

Retinal repair device and method


A device which may be formed of suitable elastomeric, biocompatible material is configured to be wedged into tenon's space between the orbital and scleral walls of the eye at the location of a retinal tear or break. When positioned, the device pushes the eye wall inward to close the tear, and fluid below the retinal wall resorbs..

06/26/14
20140176906 

Systems and methods for balancing infrared illumination in eye imaging


The field of the invention relates to systems and methods for eye imaging and, more particularly, for balancing illuminations in eye imaging. An asymmetric illumination method to compensate for the imbalance illumination caused by nose reflection is described.

06/19/14
20140172094 

Shape memory polymer intraocular lenses


A shape memory polymer (smp) intraocular lens may have a refractive index above 1.45, a tg between 10° c. And 60° c., inclusive, de minimis or an absence of glistening, and substantially 100% transmissivity of light in the visible spectrum.

06/12/14
20140163542 

System and procedure for enhancing ocular drainage


Various systems, apparatuses, and processes may be used for enhancing ocular drainage. In particular implementations, a system for ocular drainage may include an ocular interface that includes a base and a number of diathermy needles.

06/05/14
20140155871 

Method for preparing corneal donor tissue for refractive eye surgery utilizing the femtosecond laser


A method of accurately fabricating a non-human donor corneal tissue for implantation into a recipient human cornea, the method comprising the steps of: removing corneal tissue from a donor with a femtosecond laser; placing the corneal tissue in a fixative solution for a selected time interval to cross-link the collagen fibrils in the tissue and prevent swelling of the corneal tissue; and shaping the tissue to provide a conical inlay of a selected shape and thickness having one or more radial extensions. The method is such that the corneal inlay may be attached to the peripheral corneal and/or the sclera.

05/29/14
20140148486 

Sodium channel blocker delivery system with scleral lens


A scleral lens is provided with a sodium channel blocker or a sodium channel modulator disposed in the pre-corneal tear film between the scleral lens and the cornea. This system can be used to deliver sodium channel blockers or a sodium channel modulators not currently used because of poor bioavailability.

05/15/14
20140132915 

Scleral contact lens manufacturing


The different illustrative embodiments provide a method, computer program product, and apparatus for manufacturing a scleral contact lens. A number of dimensions for the scleral lens is generated based on a shape of an eye.

04/17/14
20140107777 

Implantable ophthalmic sensor cell


An implantable ophthalmic device connectable to an implantable accommodating lens includes a dual-chamber sensor cell having a first and second plate where the second plate is disposed opposite the first plate. A first chamber with a first flexible membrane is disposed on an inner side of the first plate.

04/17/14
20140107776 

Prostheses for ocular drug delivery and other treatments for glaucoma, macular degeneration, and other eye disorders or diseases


A scleral prosthesis includes an elongated body that is narrower in a middle and wider at opposing first and second ends. The body includes multiple first portions that form the first end of the body, where the first portions separated lengthwise along the body.

04/17/14
20140107566 

Methods and devices for drug delivery to ocular tissue using microneedle


Methods and devices are provided for targeted administration of a drug to a patient's eye. In one embodiment, the method includes inserting a hollow microneedle into the sclera of the eye at an insertion site and infusing a fluid drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused fluid drug formulation flows within the suprachoroidal space away from the insertion site during the infusion.

04/03/14
20140092359 

Progressive multifocal rigid gas permeable contact lens


A contact lens is provided. It is a rigid gas permeable, corneal-scleral progressive, multifocal, vision lens that covers the cornea and a portion of the sclera of an eye.

03/20/14
20140081194 

Uveoscleral shunt and methods for implanting same


Devices and methods for treating intraocular pressure are disclosed. The devices include shunts for draining aqueous humor from the anterior chamber to the uveoscleral outflow pathway, including the supraciliary space and the suprachoroidal space.

03/13/14
20140074234 

Scleral epimacular implant


The scleral epimacular implant comprises an arm (6) with a curved configuration, having a first end (1), which can be affixed to a retina (8). The arm (6) comprises a second end (3) comprising a discoidal element (4), whose internal face facing the curvature of the arm (6) is constituted as an indentation platform (5), configured to be in contact with the retina (8) when the implant is placed in said retina (8)..

03/13/14
20140074128 

Eye shape modification systems


An eye shape modification (esm) system such as a scleral buckle featuring a band having a first end, a second end opposite the first end, and a first side; and a fixation zone disposed on the first side of the band. The fixation zone is adapted to accept sutures and can be sutured to a scleral surface.

03/06/14
20140062868 

Visual display with illuminators for gaze tracking


A visual display includes hidden reference illuminators adapted to emit invisible light for generating corneo-scleral reflections on an eye watching a screen surface of the display. The tracking of such reflections and the pupil center provides input to gaze tracking.

02/20/14
20140049750 

Eye position registering and tracking


Embodiments of the invention refer to a system for registering and tracking the position of a person's eye, in particular for refractive ophthalmic surgery. According to embodiments, the system is structured such that eye images containing at least the iris and the pupil of the eye are made at a first wavelength of light and that eye images containing scleral blood vessels are made at a different second wavelength of light.

02/13/14
20140046418 

Apparatus for stimulating and/or monitoring activity in tissue


A prosthesis is provided comprising a substrate having a distal end and a proximal end; and a plurality of electrodes located at or adjacent the distal end of the substrate. The distal end of the substrate is configured for insertion, via an incision, between first and second tissue layers, such as the sclera and choroid in the eye.

02/13/14
20140046308 

Laser instrument for eye therapy


A laser instrument for therapy on the human eye, designed for surgery of the cornea, the sclera, the vitreous body or the crystalline lens, especially suitable for use in immediate succession with other instruments for eye diagnosis or eye therapy, in such a way that during the alternating use of the various instruments, the eye or at least the patient preferably remains in a predetermined position and alignment within one and the same treatment area.. .

02/06/14
20140038153 

Patient simulating mannequin eye module


A patient simulating mannequin has a head, at least one electronic visual display mounted to the head, and an electronic controller connected to the at least one electronic visual display. The at least one electronic visual display displays at least one of a plurality of eye images in response to a signal from the electronic controller.

01/16/14
20140018720 

Shunt placement through the sclera


The present invention generally relates to intraocular shunts, and in particular, to intraocular shunts configured to form a drainage pathway between the anterior chamber and the intra-tenon's space.. .

12/26/13
20130345615 

Intracorneal drug delivery device and associated methods


Methods and devices for delivering an active agent into the eye of a subject are provided. In one aspect, an ocular device for delivering an active agent through a cornea of an eye of a subject can include a housing configured to couple to the eye of the subject and a corneal seal coupled to the housing and positioned in the housing to encircle the cornea during use to form a corneal region.

12/19/13
20130337557 

Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases


The present invention refers to the use of protein kinase inhibitors and more specifically to the use of inhibitors of the protein kinase c-jun amino terminal kinase, jnk inhibitor (poly-)peptides, chimeric peptides, or of nucleic acids encoding same as well as pharmaceutical compositions containing same, for the treatment of non-chronic or chronic inflammatory eye diseases, such as inflammatory diseases of the blephara, conjunctiva, cornea, sclera, the vitreous body, uvea, ciliary body, choroid, orbital bone, lacrimal gland, or iris, in particular wherein the inflammatory disease is selected from hordeolum, chalazion, conjunktivitis, keratitis, scleritis, episcleritis, endophthalmitis, panophtalmitis, irititis, uveitis, cyclitis, chorioiditis, orbital phlegmon, and myositis of the eye muscle etc.. .

12/12/13
20130331760 

Implant for the treatment of glaucoma


The invention refers to a tube configured as an implant for insertion at least at one location into the exposed schlemm's canal of an eye and which, for example, has been mechanically dilated. The elongated tube insertable into the schlemm's canal includes a plurality openings that are arranged at the tube in axial direction distanced from each other by ring parts and that are in communication with the trabecular tissue the interior space of the tube and the aqueous humor veins of the episcleral vein system and further includes openings oriented in axial direction at a circular arc shaped segment corresponding to the cross section profile of the tube.

12/12/13
20130330383 

Ocular drug delivery system


An ocular drug delivery system can include a composition in which a formulation including recombinant human growth hormone (rhgh) is contained in a polymer matrix. The composition is configured for placement in or on the eye of a subject, and provides controlled release of an amount of the rhgh to the eye effective to promote healing of a conjunctival, sclera and or corneal wound..

12/12/13
20130330318 

Method for treating filtration failure after trabeculectomy surgery


The current invention relates to the improvement of trabeculectomy surgery. The improvement more specifically resides in an extended lifetime of the sclera-corneal drainage channel created by trabeculectomy surgery.

11/07/13
20130297015 

Customized wavefront-guided methods, systems, and devices to correct higher-order aberrations


Methods and systems for manufacturing a wavefront-guided scleral lens prosthetic device customized for an eye of a patient include obtaining a first scleral lens prosthetic device with a central optic zone configured to vault over the eye's cornea and a peripheral haptic zone configured to align with the eye's sclera, collecting measurements of any offset and/or rotation of the first scleral lens prosthetic device relative to the eye's pupil and of any aberrations, particularly higher-order aberrations, generating a wavefront-guided profile from the measurements, and fabricating a second scleral lens prosthetic device with the profile on a surface of a central optic zone configured to vault over the eye's cornea and a peripheral haptic zone customized to align with the eye's sclera.. .

10/31/13
20130289450 

Method for laser treatment for glaucoma


Because vision loss in most forms of glaucoma is related to elevated iop, most glaucoma treatment protocols are concerned with lowering iop by increasing aqueous humor outflow. The invention utilizes electromagnetic radiation to create retraction in the iris tissue, thereby (a) reducing convexity and enlarging the drainage angle and thus the area of the anterior chamber, (b) reducing contact between the zonule fibers and the iris pigment epithelium, (c) applying greater tension to both the tm and uveoscleral outflow pathways, thereby enlarging those pathways and increasing outflow..

10/17/13
20130274788 

Methods and ocular surgery


Provided are devices and methods for controlling fluid egress from the eye during ocular surgery, including an ocular seal that is signed to fit in an incision in an eye tissue such as the cornea or sclera and includes one or more lumen for passage of instruments into the eye without permitting loss of fluids through the incision. Also provided is a system for cataract surgery including a globe stabilization device, a laser lens removal device, one or more corneal seals, an infusion line, and an anterior chamber pressure monitor..

10/17/13
20130274724 

Methods and devices for treating presbyopia


Architectures and techniques for treating conditions of the eye, such as presbyopia, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement non-corneal manipulations. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the conjunctiva and sclera, to treat presbyopia.

10/17/13
20130274692 

Subconjuctival implant for posterior segment drug delivery


A therapeutic device can be configured to place the reservoir substantially between the conjunctiva and the scleral such that the size of the reservoir can be increased and the size of the scleral penetration decreased so as to decrease invasiveness. The device may comprise a substantially constant reservoir volume and drug release mechanism, in which the volume of the reservoir and mechanism are tuned to receive a quantity of therapeutic agent with a volume of injected formulation and release the therapeutic agent for an extended time with a release rate profile.



Popular terms: [SEARCH]

Sclera topics: Anterior Chamber, Conjunctiva, Aqueous Humor, Epithelium, Accommodation, Ocular Hypertension, Brachytherapy, Radionuclide, Hypertension, Laser Treatment, Retraction, Vision Loss, Presbyopia, Treatments, Cataract Surgery

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Sclera for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Sclera with additional patents listed. Browse our RSS directory or Search for other possible listings.


2.0899

4287

74 - 0 - 102